Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial
- PMID: 35392979
- PMCID: PMC8989114
- DOI: 10.1186/s13063-022-06199-8
Evaluation of the effect of targeted Mass Drug Administration and Reactive Case Detection on malaria transmission and elimination in Eastern Hararghe zone, Oromia, Ethiopia: a cluster randomized control trial
Abstract
Background: Reactive and proactive case detection measures are widely implemented by national malaria elimination programs globally. Ethiopia decided to include Reactive Case Detection (RCD) and targeted Mass Drug Administration (tMDA) approaches as part of their elimination strategy along with rigorous evaluation. The purpose of this study is to compare the impact of RCD and tMDA on malaria elimination over the 2-year study period, by looking at the annual parasite incidence before and after the intervention.
Methods: The study will be conducted in the East Hararghe zone of Ethiopia. Malaria transmission in the area is low to moderate. This study will deploy a community-based, three-arm, cluster-randomized control trial implemented over 2 years. Forty-eight clusters (16 clusters per arm) will be selected based on the annual number of confirmed malaria cases seen in the cluster. All clusters will receive the current standard of care in terms of malaria elimination interventions provided by the national malaria control program. In addition, following the identification of malaria parasite infection, individuals who reside within a 100-m radius of the index case will receive a diagnosis for malaria and treatment if positive in the RCD arm or presumptive treatment in the tMDA arm. The primary effectiveness endpoint will be measured at baseline and endline for each intervention arm and compared to the control arm using a difference in difference approach.
Discussion: This randomized controlled trial will provide evidence of the impact of the proposed intervention approaches for malaria elimination.
Trial registration: ClinicalTrials.gov NCT04241705 . Registration date: January 27, 2020.
Keywords: Cluster randomized controlled trial; Ethiopia; Malaria; Reactive case detection; Targeted mass drug administration.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- World malaria report 2019 [Internet]. [cited 2022 Mar 7]. Available from: https://www.who.int/publications/i/item/9789241565721
-
- Federal Democratic Republic of Ethiopia Ministry of Health. National Malaria Strategic Plan: 2017 - 2020. Malaria Control and Elimination Program; 2017.
-
- Deribew A, Dejene T, Kebede B, Tessema GA, Melaku YA, Misganaw A, Gebre T, Hailu A, Biadgilign S, Amberbir A, Yirsaw BD, Abajobir AA, Shafi O, Abera SF, Negussu N, Mengistu B, Amare AT, Mulugeta A, Mengistu B, Tadesse Z, Sileshi M, Cromwell E, Glenn SD, Deribe K, Stanaway JD. Incidence, prevalence and mortality rates of malaria in Ethiopia from 1990 to 2015: analysis of the global burden of diseases 2015. Malar J. 2017;16(1):271. doi: 10.1186/s12936-017-1919-4. - DOI - PMC - PubMed
-
- Federal Democratic Republic of Ethiopia Ministry of Health. Malaria Diagnosis and Treatment Guidelines for Health Workers in Ethiopia. Disease Prevention and Control Directorate National Malaria Control and Elimination Program; 2017.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
